FORMULATION AND EVALUATION OF LEVITIRACETAM MATRIX TABLETS
Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 3
Abstract
For many years the treatment of acute or chronic sicknesses were carried out normally via the transport of medication to sufferers through diverse pharmaceutical forms encompass pills, pills, creams, suppositories, drinks, ointments, aerosols and injectables. The kinds conventional oral drug delivery systems are regarded to provide delivery of the drug. Therefore to reap as well as to hold the drug awareness within the range of healing effectiveness required for the treatment. Levetiracetam matrix tablets were prepared by using different viscosity grades of Polyethylene oxides such as PEO WSR 301, PEO Coagulant and PEO 303. The matrix tablets were prepared by direct compression method. The matrix tablet formulation L-8 and L-10 which releases all the drugs in 12 hours were selected for the study of accelerated stability. All levetiracetam matrix tablets with PEO WSR 301 (L1 to L-4) were evaluated The hardness of the tablets is in the range of 13.1-14 kg/cm2. The friability below 1% indicates clearly the good mechanical resistance of the preparations of tablets. Testing of the prepared matrix tablets was found in the range of 99.1 to 101 % clearly indicates a good uniformity of content. The thickness of the tablets is in the range of 6.18 to 6.28 mm. The weight variation of tablets was within the range and 850 mg were found in all of the tablets. The matrix tablet formulation L-8 and L-10 which releases all the drugs in 12 hours were selected for the study of accelerated stability. DSC and FTIR studies were also performed. Keywords: Controlled release formulations, Levetiracetam matrix tablets, Polyethylene oxides.
IMMOBILIZATION OF Β-GLUCURONIDASE ON THE BIOMATERIALS/NANO PARTICLES AND IT’S INDUSTRIAL APPLICATIONS
β-glucuronidase enzyme belongs to the hydrolase family which perform breakdown of complex carbohydrates. β- glucuronidases are large biomolecule consists of polypeptide chains and are widely included eukaryotes and proka...
ESTIMATION OF DIFFERENT EXTRACTS OF AMARANTHUS VIRIDIS L FOR INVITRO ANTIOXIDANT ACTIVITY
Back ground: The plant Amaranthus viridis L (Amaranthaceous) is commonly known as “Never-fading flower” and “Slender amaranth” in Greek and English respectively. These plants have been traditionally used as antiulcer, an...
GENETIC ENHANCMENT OF GROUNDNUT (ARACHIS HYPOGAEA L.)THROUGH INDUCED MUIATION.
Groundnut (Arachis hypogaea L.) is a member of family Fabaceae grown for oilseed, food and animal feed. Groundnut contains 51% of monosaturated oil and 30% polyunsaturated and 19% saturated oil. India consumes over 10 mi...
CEREBROVASCULAR ACCIDENTS: CAUSE OF MOVEMENT DISORDERS IN PATIENTS
Objective: To determine number of patients suffering movements disorders after recovery from a cerebrovascular accident in Pakistan. Methodology: It is a cross sectional study, conducted at teaching hospitals of Rawalpin...
FORMULATION DEVELOPMENT OF CR OFLAXACIN MATRIX TABLET AND THEIR IN-VITRO EVALUATION
Among the all sophisticated drug deliveries oral drug delivery is known as safest and most convenient rout of administration. DDS are formulated for rapid release, for CDD (Controlled Drug delivery and release) and for t...